2 not yet recruiting, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Recruiting 1 |
Follow Venous Malformation, Low Flow: new trials by email Literature Review of Venous Malformation, Low Flow trials Research Report on Venous Malformation, Low Flow
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years. AAS at anti-inflammatory doses from 3 days to 14 days., Placebo from 3 days to 14 days., Application of Diclofenac gel 1% twice a day - Venous Malformation, Low Flow, Venous Malformations | Phase 2 | Not yet recruiting | University Hospital, Tours | 34 | 2026-09-01 | 2026-06-23 |
| A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation Apixaban (Eliquis), Placebo - Venous Malformation, Low Flow, Anticoagulants | Phase 2 | Not yet recruiting | Oslo University Hospital | 20 | 2025-02-01 | 2024-12-11 |
| A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Alpelisib, Mirdametinib - Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation | Phase 2 | Recruiting | Murdoch Childrens Research Institute | 50 | 2024-09-13 | 2026-05-05 |
Arteriovenous Malformations (1) · Lymphangioma (1) · Lymphangioma, Cystic (1) · Lymphatic Abnormalities (1) · Skin Diseases, Vascular (1) · Vascular Malformations (1)
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1) · Neoplasm, Lymphatic Tissue (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Vascular Diseases (1)
Alpelisib (1) · apixaban (1) · mirdametinib (1)
Murdoch Childrens Research Institute (1) · Oslo University Hospital (1) · University Hospital, Tours (1)
Australia (1) · France (1) · Norway (1)
Lydia Pathmanathan, MBBS, FRACP. (1) · Stephen Luen, MBChB, FRACP. (1) · Tony Penington, MBBS, FRACS. (1)